Compensation on vaccine: AIIMS director’s big announcement, money will be received on side effects
The Drugs Controller of India (DCGI) on Sunday approved the emergency use of Corona waxen. DCGI has approved the Serum Institute’s Vaccine Covishield (Covishield) and Bharat Biotech’s Vaccine Covaxin in India. AIIMS Director Dr. Randeep Guleria has given a big statement on the questions raised on the permission to use the emergency. The director of AIIMS said that if a person who is vaccinated with covaxine shows any side effects then he will be compensated. He said that this was done at the time of clinical trial also. Significantly, Congress leader Shashi Tharoor has questioned the approval of the vaccine in emergency. He said that the third phase of Bharat Biotech’s covariate has not been tested yet. Premature approval of covaxine can be dangerous. Health Minister Dr. Harsh Vardhan should clarify in this regard. The use of the corona vaccine should be avoided until the trial is complete. India should use the AstraZeneca vaccine during this time. 4 4 Also read… Announcement on the cost of vaccine: Government will have to pay 200 rupees more Dr Randeep Guleria said that if the UK’s new strains yield serious consequences, then covaccine will be used only as a backup and if there are any side effects, there is a provision for compensation. Read also… Congress leaders are not unanimous on getting approval for Corona vaccine, read who said what? The AIIMS director said in his statement that it is important to understand that when we consider a vaccine, safety is paramount and therefore the vaccine goes through different stages to ensure that it is safe, only then we humans Come in tests. All data is critically looked after by experts after which the vaccine is approved. Also read… A mountain of snow fell: Trouble rains on hundreds of people, Himachal and Kashmir tremble Guleria said that it is a very good day for our country and a very good way to start the new year. Both vaccines are made in India. They are effective and easy to maintain. We should start vaccinating, in a very short time.